191 related articles for article (PubMed ID: 36217192)
21. Investigating the plasma-liver-brain axis of omega-3 fatty acid metabolism in mouse knock-in for the human apolipoprotein E epsilon 4 allele.
Husain MA; Vachon A; Chouinard-Watkins R; Vandal M; Calon F; Plourde M
J Nutr Biochem; 2023 Jan; 111():109181. PubMed ID: 36220526
[TBL] [Abstract][Full Text] [Related]
22. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.
Conejero-Goldberg C; Hyde TM; Chen S; Dreses-Werringloer U; Herman MM; Kleinman JE; Davies P; Goldberg TE
Mol Psychiatry; 2011 Aug; 16(8):836-47. PubMed ID: 20479757
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
24. APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
Jin Y; Li F; Sonoustoun B; Kondru NC; Martens YA; Qiao W; Heckman MG; Ikezu TC; Li Z; Burgess JD; Amerna D; O'Leary J; DeTure MA; Zhao J; McLean PJ; Dickson DW; Ross OA; Bu G; Zhao N
Acta Neuropathol; 2022 Jun; 143(6):641-662. PubMed ID: 35471463
[TBL] [Abstract][Full Text] [Related]
25. Leading determinants of incident dementia among individuals with and without the apolipoprotein E ε4 genotype: a retrospective cohort study.
Ye S; Roccati E; Wang W; Zhu Z; Kiburg K; Huang Y; Zhang X; Zhang X; Liu J; Tang S; Hu Y; Ge Z; Yu H; He M; Shang X
BMC Neurol; 2024 Feb; 24(1):71. PubMed ID: 38378514
[TBL] [Abstract][Full Text] [Related]
26. Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer's Dementia in the Oldest Old.
Melo van Lent D; Egert S; Wolfsgruber S; Kleineidam L; Weinhold L; Wagner-Thelen H; Maier W; Jessen F; Ramirez A; Schmid M; Scherer M; Riedel-Heller SG; Wagner M
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33573174
[TBL] [Abstract][Full Text] [Related]
27. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.
Franzmeier N; Suárez-Calvet M; Frontzkowski L; Moore A; Hohman TJ; Morenas-Rodriguez E; Nuscher B; Shaw L; Trojanowski JQ; Dichgans M; Kleinberger G; Haass C; Ewers M;
Mol Neurodegener; 2020 Oct; 15(1):57. PubMed ID: 33032659
[TBL] [Abstract][Full Text] [Related]
28. Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies.
Pires M; Rego AC
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614219
[No Abstract] [Full Text] [Related]
29. Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.
Kobayashi S; Tateno M; Park TW; Utsumi K; Sohma H; Ito YM; Kokai Y; Saito T
PLoS One; 2011 Apr; 6(4):e18569. PubMed ID: 21552550
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.
Agosta F; Vossel KA; Miller BL; Migliaccio R; Bonasera SJ; Filippi M; Boxer AL; Karydas A; Possin KL; Gorno-Tempini ML
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2018-22. PubMed ID: 19164761
[TBL] [Abstract][Full Text] [Related]
31. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease.
Kanai M; Shizuka M; Urakami K; Matsubara E; Harigaya Y; Okamoto K; Shoji M
Neurosci Lett; 1999 May; 267(1):65-8. PubMed ID: 10400250
[TBL] [Abstract][Full Text] [Related]
33. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
34. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
[TBL] [Abstract][Full Text] [Related]
35. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
[TBL] [Abstract][Full Text] [Related]
36. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.
Tao Q; Ang TFA; DeCarli C; Auerbach SH; Devine S; Stein TD; Zhang X; Massaro J; Au R; Qiu WQ
JAMA Netw Open; 2018 Oct; 1(6):e183597. PubMed ID: 30646251
[TBL] [Abstract][Full Text] [Related]
37. Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of AD.
Goikolea J; Gerenu G; Daniilidou M; Mangialasche F; Mecocci P; Ngandu T; Rinne J; Solomon A; Kivipelto M; Cedazo-Minguez A; Sandebring-Matton A; Maioli S
Alzheimers Res Ther; 2022 Feb; 14(1):37. PubMed ID: 35209952
[TBL] [Abstract][Full Text] [Related]
38. Altered SPMs and age-associated decrease in brain DHA in
Martinsen A; Tejera N; Vauzour D; Harden G; Dick J; Shinde S; Barden A; Mori TA; Minihane AM
FASEB J; 2019 Sep; 33(9):10315-10326. PubMed ID: 31251078
[TBL] [Abstract][Full Text] [Related]
39. Effects of apolipoprotein E4 genotype on cerebro-cerebellar connectivity, brain atrophy, and cognition in patients with Alzheimer's disease.
de Dieu Uwisengeyimana J; Wang Y; Nguchu BA; Wang X; Qiu B
J Neurol Sci; 2022 Nov; 442():120435. PubMed ID: 36201963
[TBL] [Abstract][Full Text] [Related]
40. Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
Morris JK; Uy RAZ; Vidoni ED; Wilkins HM; Archer AE; Thyfault JP; Miles JM; Burns JM
J Alzheimers Dis; 2017; 58(4):1129-1135. PubMed ID: 28550261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
